The use of weight-lowering drugs, any investigational blood-glucose or lipid-lowering agent (other than statins or ezetimibe) within the past 3 months
Previous treatment with systemic corticosteroids or a change in dosage of thyroid hormones in the previous 6 weeks
The use of insulin within the 3 months prior to screening
Others

NCT02823808_exc_T1
Qualifier
weight-lowering
NCT02823808_exc_T2
Drug
drugs
NCT02823808_exc_T3
Qualifier
investigational
NCT02823808_exc_T4
Qualifier
lipid-lowering
NCT02823808_exc_T5
Qualifier
blood-glucose
NCT02823808_exc_T6
Drug
agent
NCT02823808_exc_T7
Scope
blood-glucose or lipid-lowering
NCT02823808_exc_T8
Temporal
past 3 months
NCT02823808_exc_T9
Negation
other
NCT02823808_exc_T10
Drug
statins
NCT02823808_exc_T11
Drug
ezetimibe
NCT02823808_exc_T12
Scope
statins or ezetimibe
NCT02823808_exc_T13
Scope
weight-lowering drugs, any investigational blood-glucose or lipid-lowering agent
NCT02823808_exc_T14
Drug
systemic corticosteroids
NCT02823808_exc_T15
Drug
thyroid hormones
NCT02823808_exc_T16
Qualifier
change in dosage
NCT02823808_exc_T17
Temporal
previous 6 weeks
NCT02823808_exc_T18
Scope
systemic corticosteroids or a change in dosage of thyroid hormones
NCT02823808_exc_T19
Drug
insulin
NCT02823808_exc_T20
Temporal
within the 3 months prior to screening
NCT02823808_exc_T21
Reference_point
screening